OpenURL Connection Search

Select item for more details and to access through your institution.

The role of erythrocytapheresis in secondary erythrocytosis therapy.
Published in:
Clinical Hemorheology & Microcirculation, 2002, v. 26, n. 4, p. 273
By:
- Bláha, M.;
- Skořepová, M.;
- Mašín, V.;
- Špásová, I.;
- Paráková, Z.;
- Malý, J.;
- žák, P.;
- Belada, D.;
- Turková, A.
Publication type:
Article
Léčba relabovaného a refrakterního Hodgkinova lymfomu - doporučení české studijní skupiny Hodgkinův lymfom.
Published in:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie, 2016, v. 29, n. 5, p. 342, doi. 10.14735/amko2016342
By:
- H., Móciková;
- J., Marková;
- Ľ., Gahérová;
- Z., Král;
- A., Sýkorová;
- D., Belada;
- V., Procházka;
- L., Martínková;
- T., Papajík;
- T., Kozák
Publication type:
Article
Hodnocení klinického stadia a léčebné odpovědi u maligních lymfomů -- doporučení Kooperativní lymfomové skupiny na základě revidovaných kritérií z roku 2014 (Luganská klasifikace).
Published in:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie, 2016, v. 29, n. 4, p. 295, doi. 10.14735/amko2016295
By:
- Sýkorová, A.;
- Pytlík, R.;
- Móciková, H.;
- Belada, D.;
- Benešová, K.;
- Papajík, T.;
- Janíková, A.;
- Šálek, D.;
- Procházka, V.;
- Vokurka, S.;
- Campr, V.;
- Klener, P.;
- Kubáčková, K.;
- Trněný, M.
Publication type:
Article
Léčba a prognóza pacientů s relabovaným nebo refrakterním Hodgkinovým lymfomem nevhodných k transplantaci kmenových buněk.
Published in:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie, 2014, v. 27, n. 6, p. 424, doi. 10.14735/amko2014424
By:
- Móciková, H.;
- Sýkorová, A.;
- Štěpánková, P.;
- Marková, J.;
- Michalka, J.;
- Král, Z.;
- Burešová, L.;
- Belada, D.
Publication type:
Article
Postavení radioterapie v léčbě maligních lymfomů -- doporučení Kooperativní lymfomové skupiny.
Published in:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie, 2013, v. 26, n. 3, p. 99
By:
- Dědečková, K.;
- Móciková, H.;
- Belada, D.;
- Janíková, A.;
- Dolečková, M.;
- Malinová, B.;
- Feltl, D.;
- Vošmik, M.;
- Svoboda, T.;
- Marková, J.;
- Trněný, M.
Publication type:
Article
Postavení radioterapie v léčbě maligních lymfomů doporučení Kooperativní lymfomové skupiny.
Published in:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie, 2013, v. 26, n. 2, p. 99
By:
- Dědečková, K.;
- Móciková, H.;
- Belada, D.;
- Janíková, A.;
- Dolečková, M.;
- Malinová, B.;
- Feltl, D.;
- Vošmik, M.;
- Svoboda, T.;
- Marková, J.;
- Trněný, M.
Publication type:
Article
Léčba pacientů s relabovaným/refraktérním Hodgkinovým lymfomem.
Published in:
Journal of the Czech & Slovak Societies for Oncology / Klinická Onkologie, 2011, v. 24, n. 2, p. 121
By:
- Mociková, H.;
- Pytlík, R.;
- Raida, L.;
- Sýkorová, A.;
- Marková, J.;
- Král, Z.;
- Jindra, P.;
- Steinerová, K.;
- Válková, V.;
- Trnková, M.;
- Vacková, B.;
- Trněný, M.;
- Indrák, K.;
- Belada, D.;
- Mayer, J.;
- Koza, V.;
- Kozák, T.
Publication type:
Article
Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL).
Published in:
Annals of Hematology, 2022, v. 101, n. 4, p. 789, doi. 10.1007/s00277-022-04759-1
By:
- Janikova, A.;
- Michalka, J.;
- Chloupkova, R.;
- Kopalova, N.;
- Campr, V.;
- Kamaradova, K.;
- Kren, L.;
- Belada, D.;
- Benesova, K.;
- Dlouha, J.;
- Klener, P.;
- Procházka, V.;
- Mocikova, H.;
- Duras, J.;
- Trneny, M.
Publication type:
Article
Změny v imunitním systému u neléčených nemocných s chronickou lymfocytární leukémií - část 2: nespecifická imunita.
Published in:
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2021, v. 27, n. 3, p. 218, doi. 10.48095/cctahd2021218
By:
- Vodárek, P.;
- Smolej, L.;
- Belada, D.;
- Šimkovič, M.;
- Écsiová, D.;
- Žák, P.
Publication type:
Article
Změny v imunitním systému u neléčených nemocných s chronickou lymfocytární leukemií - část 1: specifická imunita.
Published in:
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2021, v. 27, n. 2, p. 128, doi. 10.48095/cctahd2021128
By:
- Vodárek, P.;
- Smolej, L.;
- Belada, D.;
- Šimkovič, M.;
- Écsiová, D.;
- Žák, P.
Publication type:
Article
Léčba CD19 pozitivních hematologických malignit T-lymfocyty s chimérickým antigenním receptorem (CAR-T-lymfocyty). Přehled a vlastní zkušenosti s preparátem tisagenlecleucel (Kymriah) u prvních deseti pacientů
Published in:
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2020, v. 26, p. 17
By:
- Pytlík, R.;
- Gašová, Z.;
- Rahmatová, Š.;
- Čemusová, B.;
- Bhuiyanová-Ludvíková, Z.;
- Viktorová, D.;
- Válková, V.;
- Bohmová, M.;
- Soukup, P.;
- Slouková, M.;
- Štach, M.;
- Trněný, M.;
- Belada, D.;
- Mociková, H.;
- Ďuraš, J.;
- Šimonová, R.;
- Vranický, A.;
- Otáhal, P.;
- Vydra, J.
Publication type:
Article
Rozvoj Richterovy transformace u nemocného s refrakterní chronickou lymfocytární leukemií na léčbě ibrutinibem.
Published in:
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2020, v. 26, n. 1, p. 56
By:
- Smolej, L.;
- Šimkovič, M.;
- Zavřelová, A.;
- Kašparová, P.;
- Hoffmann, P.;
- Dvořák, P.;
- Slanina, M.;
- Krčálová, E.;
- Belada, D.;
- Žák, P.
Publication type:
Article
Maligní lymfomy nehodgkinova typu v dokumentaci Stomatologické kliniky v Hradci Králové 1998-2008.
Published in:
Czech Dental Journal / Ceská Stomatologie a Praktické Zubni Lékarstvi, 2011, v. 111, n. 2, p. 36, doi. 10.51479/cspzl.2011.007
By:
- Nováková, V.;
- Belada, D.;
- Laco, J.;
- Ka؞parová, P.;
- Nová, M.
Publication type:
Article
EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVIDES DURABLE RESPONSES IN HIGH‐RISK FOLLICULAR LYMPHOMA, REGARDLESS OF POD24 STATUS.
Published in:
Hematological Oncology, 2023, v. 41, p. 125, doi. 10.1002/hon.3163_84
By:
- Belada, D.;
- Falchi, L.;
- Leppä, S.;
- Vermaat, J. S.;
- Holte, H.;
- Hutchings, M.;
- Lugtenburg, P.;
- de Vos, S.;
- Abrisqueta, P.;
- Nijland, M.;
- Merryman, R. W.;
- Christensen, J. H.;
- Wahlin, B. E.;
- Linton, K. M.;
- Wang, L.;
- Abbas, A.;
- Rana, A.;
- Quadri, S.;
- Sureda, A.
Publication type:
Article
OUTCOMES OF THE TREATMENT AFTER ANTI‐CD19 CAR‐T THERAPY FAILURE IN PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA—ANALYSIS OF DATA FROM THE CZECH REPUBLIC.
Published in:
Hematological Oncology, 2023, v. 41, p. 792, doi. 10.1002/hon.3165_640
By:
- Sýkorová, A.;
- Polgárová, K.;
- Folber, F.;
- Ďuraš, J.;
- Móciková, H.;
- Steinerová, K.;
- Obr, A.;
- Belada, D.;
- Smolej, L.;
- Trněný, M.;
- Pytlík, R.
Publication type:
Article
ANALYSIS OF PATIENTS IN THE FIRST RELAPSE OR PROGRESSION OF T‐CELL LYMPHOMA. REAL WORLD DATA FROM CZECH LYMPHOMA STUDY GROUP REGISTRY (NIHIL).
Published in:
Hematological Oncology, 2023, v. 41, p. 764, doi. 10.1002/hon.3165_610
By:
- Janikova, A.;
- Belada, D.;
- Klanova, M.;
- Chloupkova, R.;
- Kopalova, N.;
- Campr, V.;
- Kamaradova, K.;
- Prochazka, V.;
- Benesova, K.;
- Mocikova, H.;
- Duras, J.;
- Trneny, M.
Publication type:
Article
BRENTUXIMAB VEDOTIN IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED CD30‐POSITIVE PERIPHERAL T‐CELL LYMPHOMAS: REAL‐WORLD DATA.
Published in:
Hematological Oncology, 2023, v. 41, p. 763, doi. 10.1002/hon.3165_609
By:
- Klanova, M.;
- Sykorova, A.;
- Janikova, A.;
- Mocikova, H.;
- Duras, J.;
- Prochazka, V.;
- Pukyova, J.;
- Klener, P.;
- Belada, D.;
- Kopalova, N.;
- Benesova, K.;
- Campr, V.;
- Blahovcova, P.;
- Trneny, M.
Publication type:
Article
HOW WE ARE SUCCESSFUL IN THERAPY OF T‐CELL LYMPHOMA PATIENTS (≥70 YEARS). REAL‐WORDL ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP REGISTRY (NIHIL).
Published in:
Hematological Oncology, 2023, v. 41, p. 762, doi. 10.1002/hon.3165_608
By:
- Janikova, A.;
- Klanova, M.;
- Belada, D.;
- Chloupkova, R.;
- Campr, V.;
- Kamaradova, K.;
- Kopalova, N.;
- Benesova, K.;
- Prochazka, V.;
- Mocikova, H.;
- Duras, J.;
- Trneny, M.
Publication type:
Article
IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO POLA‐R‐CHP TREATMENT REDUCES TUMOR MICROENVIRONMENT DEPENDENCY.
Published in:
Hematological Oncology, 2023, v. 41, p. 223, doi. 10.1002/hon.3163_146
By:
- Morschhauser, F.;
- Hatzi, K.;
- Lenz, G.;
- Herrera, A. F.;
- Flowers, C. R.;
- Trněný, M.;
- Burke, J. M.;
- Hou, J.;
- Staber, P. B.;
- Hawkes, E. A.;
- Izutsu, K.;
- Le Gouill, S.;
- Belada, D.;
- Tucci, A.;
- Yan, M.;
- Harris, W.;
- Hirata, J.;
- Lee, C.;
- Jiang, Y.;
- Jardin, F.
Publication type:
Article
HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R‐CHOP IN PREVIOUSLY UNTREATED (1L) HIGH‐RISK DLBCL, INCLUDING DOUBLE‐HIT/TRIPLE‐HIT: EPCORE NHL‐2 UPDATE.
Published in:
Hematological Oncology, 2023, v. 41, p. 207, doi. 10.1002/hon.3163_135
By:
- Falchi, L.;
- Clausen, M. R.;
- Offner, F.;
- de Vos, S.;
- Brody, J.;
- Linton, K. M.;
- Snauwaert, S.;
- Cordoba, R.;
- Wu, J.;
- Bykhovski, I.;
- Wang, L.;
- Rana, A.;
- Belada, D.
Publication type:
Article
POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA IN THE REAL WORLD.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.43_2881
By:
- Vodicka, P;
- Benesova, K;
- Janikova, A;
- Prochazka, V;
- Belada, D;
- Mocikova, H;
- Steinerova, K;
- Duras, J;
- Karban, J;
- Hanackova, V;
- Sykorova, A;
- Obr, A;
- Trneny, M
Publication type:
Article
MULTICENTER RETROSPECTIVE ANALYSIS OF RISK FACTORS FOR MORTALITY OF COVID‐19 INFECTION IN PATIENTS WITH LYMPHOMA.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.197_2880
By:
- Kořen, J.;
- Steinerová, K.;
- Janíková, A.;
- Belada, D.;
- Hájková, B.;
- Krčméryová, M.;
- Hanáčková, V.;
- Vacková, B.;
- Jindra, P.;
- Osovská, M.;
- Svobodová, E.;
- Dlouhá, L.;
- Vodička, P.;
- Trněný, M.
Publication type:
Article
FIRST‐MIND: A PHASE IB, OPEN‐LABEL, RANDOMIZED STUDY TO ASSESS SAFETY OF TAFASITAMAB OR TAFASITAMAB + LENALIDOMIDE IN ADDITION TO R‐CHOP IN PATIENTS WITH NEWLY DIAGNOSED DLBCL.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.149_2880
By:
- Belada, D;
- Kopeckova, K;
- Bergua Burgues, J. M;
- André, M;
- Pérez Persona, E;
- Pichler, P;
- Klöpfer, P;
- Brackertz, B;
- Lohrmann, E;
- Lahiry, A;
- Shah, N;
- Brugger, W;
- Burke, J. M;
- Nowakowski, G. S
Publication type:
Article
PERIPHERAL T‐CELL LYMPHOMAS INVOLVING CENTRAL NERVOUS SYSTEM: A REPORT FROM THE CZECH LYMPHOMA STUDY GROUP REGISTRY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.132_2880
By:
- Mocikova, H.;
- Pytlik, R.;
- Benesova, K.;
- Janikova, A.;
- Duras, J.;
- Sykorova, A.;
- Steinerova, K.;
- Prochazka, V.;
- Campr, V.;
- Belada, D.;
- Dlouha, J.;
- Trneny, M.
Publication type:
Article
RESPONSE TO A+CHP BY CD30 EXPRESSION IN THE ECHELON‐2 TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 281, doi. 10.1002/hon.92_2630
By:
- Illidge, T.;
- Horwitz, S.;
- Iyer, S.;
- Bartlett, N.;
- Kim, W.;
- Tilly, H.;
- Belada, D.;
- Feldman, T.;
- Illés, Á.;
- Jacobsen, E.;
- Hüttmann, A.;
- Zinzani, P.;
- O'Connor, O.A.;
- Trepicchio, W.;
- Miao, H.;
- Rao, S.;
- Onsum, M.;
- Manley, T.;
- Advani, R.
Publication type:
Article
PROGNOSTIC VALUE OF THE INTERVAL BETWEEN RELAPSE AND THERAPY INITIATION IN DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS. ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP DATABASE.
Published in:
Hematological Oncology, 2019, v. 37, p. 413, doi. 10.1002/hon.83_2631
By:
- Janikova, A.;
- Chloupkova, R.;
- Campr, V.;
- Kopalova, N.;
- Klener, P.;
- Benesova, K.;
- Hamouzova, J.;
- Belada, D.;
- Sykorova, A.;
- Prochazka, V.;
- Pirnos, J.;
- Duras, J.;
- Mocikova, H.;
- Michalka, J.;
- Trneny, M.
Publication type:
Article
PREDICTIVE VALUE OF PRIMA‐PROGNOSTIC INDEX (PRIMA‐PI) IN FIRST RELAPSE OF FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 398, doi. 10.1002/hon.68_2631
By:
- Ďuraš, J.;
- Procházka, V.;
- Belada, D.;
- Janíková, A.;
- Móciková, H.;
- Kopečková, K.;
- Hájek, R.;
- Trněný, M.
Publication type:
Article
IS IT RADIOTHERAPY NECESSARY FOR PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBL) PATIENTS ACHIEVING PET NEGATIVITY AFTER IMMUNOCHEMOTHERAPY?
Published in:
Hematological Oncology, 2019, v. 37, p. 267, doi. 10.1002/hon.77_2630
By:
- Trneny, M.;
- Polgarova, K.;
- Janikova, A.;
- Belada, D.;
- Prochazka, V.;
- Duras, J.;
- Mocikova, H.;
- Steinerova, K.;
- Campr, V.;
- Blahovcova, P.;
- Petrova, M.;
- Zogala, D.;
- Ptacnik, V.
Publication type:
Article
ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R<sup>2</sup>‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma.
Published in:
Hematological Oncology, 2019, v. 37, p. 36, doi. 10.1002/hon.5_2629
By:
- Vitolo, U.;
- Witzig, T.E.;
- Gascoyne, R.D.;
- Scott, D.W.;
- Zhang, Q.;
- Jurczak, W.;
- Özcan, M.;
- Hong, X.;
- Zhu, J.;
- Jin, J.;
- Belada, D.;
- Bergua, J.M.;
- Piazza, F.;
- Mócikova, H.;
- Molinari, A.L.;
- Yoon, D.H.;
- Cavallo, F.;
- Tani, M.;
- Izutsu, K.;
- Kato, K.
Publication type:
Article
A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT‐NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 554, doi. 10.1002/hon.2632
By:
- Wang, M.;
- Belada, D.;
- Cheah, C.;
- Chu, M.P.;
- Dreyling, M.;
- Flinn, I.;
- Fogliatto, L.;
- Goy, A.;
- Inwards, D.;
- Jurczak, W.;
- Mayer, J.;
- Re, F.;
- Robak, T.;
- Spurgeon, S.;
- Yoon, S.S.;
- Zinzani, P.L.;
- Yin, M.;
- Chen, T.;
- Kahl, B.
Publication type:
Article
EXTRANODAL NATURAL KILLER (NK)/T‐CELL LYMPHOMA, NASAL TYPE – CASE REPORT AND REVIEW OF CZECH LYMPHOMA STUDY GROUP (CLSG) DATABASE.
Published in:
Hematological Oncology, 2019, v. 37, p. 478, doi. 10.1002/hon.157_2631
By:
- Steinerova, K.;
- Jindra, P.;
- Lysak, D.;
- Karas, M.;
- Trneny, M.;
- Klener, P.;
- Sykorova, A.;
- Belada, D.;
- Janikova, A.;
- Pytlik, R.;
- Prochazka, V.;
- Benesova, K.;
- Blahovcova, P.
Publication type:
Article
T‐CELL LYMPHOMA IN THE ELDERLY PATIENTS. WHO IS YOUNG, OLD, AND ELDERLY?
Published in:
Hematological Oncology, 2019, v. 37, p. 465, doi. 10.1002/hon.145_2631
By:
- Janikova, A.;
- Chloupkova, R.;
- Klener, P.;
- Benesova, K.;
- Campr, V.;
- Belada, D.;
- Sykorova, A.;
- Prochazka, V.;
- Kopalova, N.;
- Hamouzova, J.;
- Pirnos, J.;
- Duras, J.;
- Mocikova, H.;
- Trneny, M.
Publication type:
Article
PHASE 2 STUDY OF PARSACLISIB (INCB050465) FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) (CITADEL‐202).
Published in:
Hematological Oncology, 2019, v. 37, p. 326, doi. 10.1002/hon.138_2630
By:
- Belada, D.;
- Fay, K.;
- Casasnovas, R.;
- Gressin, R.;
- Lee, H.;
- Mehta, A.;
- Munoz, J.;
- Verhoef, G.;
- Corrado, C.;
- DeMarini, D.;
- Zhao, W.;
- Chen, X.;
- Coleman, M.
Publication type:
Article
DA‐EPOCH‐R VERSUS R‐CHOP IN HIGH RISK DLBCL PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP (CLSG).
Published in:
Hematological Oncology, 2019, v. 37, p. 433, doi. 10.1002/hon.107_2631
By:
- Šimkovič, M.;
- Móciková, H.;
- Ďuraš, J.;
- Kamarádová, K.;
- Štěpánková, P.;
- Janíková, A.;
- Michalka, J.;
- Žák, P.;
- Belada, D.;
- Trněný, M.
Publication type:
Article
RESPONSE TO A+CHP BY CD30 EXPRESSION IN THE ECHELON‐2 TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 281, doi. 10.1002/hon.92_2630
By:
- Illidge, T.;
- Horwitz, S.;
- Iyer, S.;
- Bartlett, N.;
- Kim, W.;
- Tilly, H.;
- Belada, D.;
- Feldman, T.;
- Illés, Á.;
- Jacobsen, E.;
- Hüttmann, A.;
- Zinzani, P.;
- O'Connor, O.A.;
- Trepicchio, W.;
- Miao, H.;
- Rao, S.;
- Onsum, M.;
- Manley, T.;
- Advani, R.
Publication type:
Article
PROGNOSTIC VALUE OF THE INTERVAL BETWEEN RELAPSE AND THERAPY INITIATION IN DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS. ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP DATABASE.
Published in:
Hematological Oncology, 2019, v. 37, p. 413, doi. 10.1002/hon.83_2631
By:
- Janikova, A.;
- Chloupkova, R.;
- Campr, V.;
- Kopalova, N.;
- Klener, P.;
- Benesova, K.;
- Hamouzova, J.;
- Belada, D.;
- Sykorova, A.;
- Prochazka, V.;
- Pirnos, J.;
- Duras, J.;
- Mocikova, H.;
- Michalka, J.;
- Trneny, M.
Publication type:
Article
IS IT RADIOTHERAPY NECESSARY FOR PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBL) PATIENTS ACHIEVING PET NEGATIVITY AFTER IMMUNOCHEMOTHERAPY?
Published in:
Hematological Oncology, 2019, v. 37, p. 267, doi. 10.1002/hon.77_2630
By:
- Trneny, M.;
- Polgarova, K.;
- Janikova, A.;
- Belada, D.;
- Prochazka, V.;
- Duras, J.;
- Mocikova, H.;
- Steinerova, K.;
- Campr, V.;
- Blahovcova, P.;
- Petrova, M.;
- Zogala, D.;
- Ptacnik, V.
Publication type:
Article
PREDICTIVE VALUE OF PRIMA‐PROGNOSTIC INDEX (PRIMA‐PI) IN FIRST RELAPSE OF FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 398, doi. 10.1002/hon.68_2631
By:
- Ďuraš, J.;
- Procházka, V.;
- Belada, D.;
- Janíková, A.;
- Móciková, H.;
- Kopečková, K.;
- Hájek, R.;
- Trněný, M.
Publication type:
Article
ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R<sup>2</sup>‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma.
Published in:
Hematological Oncology, 2019, v. 37, p. 36, doi. 10.1002/hon.5_2629
By:
- Vitolo, U.;
- Witzig, T.E.;
- Gascoyne, R.D.;
- Scott, D.W.;
- Zhang, Q.;
- Jurczak, W.;
- Özcan, M.;
- Hong, X.;
- Zhu, J.;
- Jin, J.;
- Belada, D.;
- Bergua, J.M.;
- Piazza, F.;
- Mócikova, H.;
- Molinari, A.L.;
- Yoon, D.H.;
- Cavallo, F.;
- Tani, M.;
- Izutsu, K.;
- Kato, K.
Publication type:
Article
A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT‐NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 554, doi. 10.1002/hon.2632
By:
- Wang, M.;
- Belada, D.;
- Cheah, C.;
- Chu, M.P.;
- Dreyling, M.;
- Flinn, I.;
- Fogliatto, L.;
- Goy, A.;
- Inwards, D.;
- Jurczak, W.;
- Mayer, J.;
- Re, F.;
- Robak, T.;
- Spurgeon, S.;
- Yoon, S.S.;
- Zinzani, P.L.;
- Yin, M.;
- Chen, T.;
- Kahl, B.
Publication type:
Article
EXTRANODAL NATURAL KILLER (NK)/T‐CELL LYMPHOMA, NASAL TYPE – CASE REPORT AND REVIEW OF CZECH LYMPHOMA STUDY GROUP (CLSG) DATABASE.
Published in:
Hematological Oncology, 2019, v. 37, p. 478, doi. 10.1002/hon.157_2631
By:
- Steinerova, K.;
- Jindra, P.;
- Lysak, D.;
- Karas, M.;
- Trneny, M.;
- Klener, P.;
- Sykorova, A.;
- Belada, D.;
- Janikova, A.;
- Pytlik, R.;
- Prochazka, V.;
- Benesova, K.;
- Blahovcova, P.
Publication type:
Article
T‐CELL LYMPHOMA IN THE ELDERLY PATIENTS. WHO IS YOUNG, OLD, AND ELDERLY?
Published in:
Hematological Oncology, 2019, v. 37, p. 465, doi. 10.1002/hon.145_2631
By:
- Janikova, A.;
- Chloupkova, R.;
- Klener, P.;
- Benesova, K.;
- Campr, V.;
- Belada, D.;
- Sykorova, A.;
- Prochazka, V.;
- Kopalova, N.;
- Hamouzova, J.;
- Pirnos, J.;
- Duras, J.;
- Mocikova, H.;
- Trneny, M.
Publication type:
Article
PHASE 2 STUDY OF PARSACLISIB (INCB050465) FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) (CITADEL‐202).
Published in:
Hematological Oncology, 2019, v. 37, p. 326, doi. 10.1002/hon.138_2630
By:
- Belada, D.;
- Fay, K.;
- Casasnovas, R.;
- Gressin, R.;
- Lee, H.;
- Mehta, A.;
- Munoz, J.;
- Verhoef, G.;
- Corrado, C.;
- DeMarini, D.;
- Zhao, W.;
- Chen, X.;
- Coleman, M.
Publication type:
Article
DA‐EPOCH‐R VERSUS R‐CHOP IN HIGH RISK DLBCL PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP (CLSG).
Published in:
Hematological Oncology, 2019, v. 37, p. 433, doi. 10.1002/hon.107_2631
By:
- Šimkovič, M.;
- Móciková, H.;
- Ďuraš, J.;
- Kamarádová, K.;
- Štěpánková, P.;
- Janíková, A.;
- Michalka, J.;
- Žák, P.;
- Belada, D.;
- Trněný, M.
Publication type:
Article
MAINTENANCE RITUXIMAB IMPROVES SURVIVAL IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP.
Published in:
Hematological Oncology, 2017, v. 35, p. 205, doi. 10.1002/hon.2438_69
By:
- Obr, A.;
- Klener, P.;
- Belada, D.;
- Pytlik, R.;
- Simkovic, M.;
- Salek, D.;
- Mocikova, H.;
- Prochazka, V.;
- Janikova, A.;
- Markova, J.;
- Campr, V.;
- Kodet, R.;
- Trneny, M.
Publication type:
Article
R-CHOP/R-HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS.
Published in:
Hematological Oncology, 2017, v. 35, p. 204, doi. 10.1002/hon.2438_68
By:
- Klener, P.;
- Fronkova, E.;
- Belada, D.;
- Forsterova, K.;
- Pytlik, R.;
- Kalinova, M.;
- Simkovic, M.;
- Salek, D.;
- Mocikova, H.;
- Prochazka, V.;
- Blahovcová, P.;
- Janikova, A.;
- Markova, J.;
- Obr, A.;
- Berkova, A.;
- Vaskova, M.;
- Mejstrikova, E.;
- Campr, V.;
- Kubinyi, J.;
- Jaksa, R.
Publication type:
Article
Beyond rituximab maintenance. relapsing follicular lymphoma during or after end of rituximab maintenance: analysis of Czech Lymphoma Study Group ( CLSG) database.
Published in:
Hematological Oncology, 2017, v. 35, p. 362, doi. 10.1002/hon.2439_117
By:
- Janikova, A.;
- Campr, V.;
- Kopalova, N.;
- Benesova, K.;
- Belada, D.;
- Prochazka, V.;
- Duras, J.;
- Dlouha, J.;
- Mocikova, H.;
- Sykorova, A.;
- Brejcha, M.;
- Mayer, J.;
- Trneny, M.
Publication type:
Article
PROGNOSTIC VALUE OF PET-CT AFTER FIRST-LINE IMMUNOCHEMOTHERAPY FOR FOLLICULAR LYMPHOMA IN THE PHASE III GALLIUM STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 38, doi. 10.1002/hon.2437_20
By:
- Trotman, J.;
- Barrington, S.;
- Belada, D.;
- Meignan, M.;
- MacEwan, R.;
- Owen, C.;
- Ptáčník, V.;
- Rosta, A.;
- Fingerle ‐ Rowson, G.;
- Mattiello, F.;
- Nielsen, T.;
- Sahin, D.;
- Hiddemann, W.;
- Marcus, R.;
- Davies, A.
Publication type:
Article
cardiac lymphomas: Incidence and outcome in newly diagnosed non- Hodgkin's lymphomas. Analysis from the Czech lymphoma study group ( CLSG) database.
Published in:
Hematological Oncology, 2017, v. 35, p. 328, doi. 10.1002/hon.2439_72
By:
- Janikova, A.;
- Lobello, C.;
- Kren, L.;
- Hermanova, M.;
- Sprlakova ‐ Pukova, A.;
- Krejci, J.;
- Pospisilova, S.;
- Pytlik, R.;
- Dlouha, J.;
- Belada, D.;
- Prochazka, V.;
- Duras, J.;
- Mocikova, H.;
- Mayer, J.;
- Trneny, M.
Publication type:
Article
MINIMAL RESIDUAL DISEASE AND OUTCOMES IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) IN THE PHASE III GADOLIN TRIAL OF OBINUTUZUMAB AND BENDAMUSTINE VS BENDAMUSTINE.
Published in:
Hematological Oncology, 2017, v. 35, p. 216, doi. 10.1002/hon.2438_80
By:
- Pott, C.;
- Belada, D.;
- Danesi, N.;
- Fingerle ‐ Rowson, G.R.;
- Gribben, J.;
- Harbron, C.G.;
- Hoster, E.;
- Kahl, B.S.;
- Kehden, B.;
- Mundt, K.E.;
- Nicolas ‐ Virelizier, E.;
- Sehn, L.H.;
- Cheson, B.D.
Publication type:
Article

Found: 56